{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:58:18Z","timestamp":1780534698038,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.humpath.2013.02.016","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T07:19:10Z","timestamp":1367911150000},"page":"1882-1889","source":"Crossref","is-referenced-by-count":30,"title":["CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis"],"prefix":"10.1016","volume":"44","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.02.016_bb0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200310024","article-title":"Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation","volume":"165","author":"Nagano","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0065-230X(08)60101-3","article-title":"CD44: structure, function, and association with the malignant process","volume":"71","author":"Naor","year":"1997","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.016_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/B:HIJO.0000032354.94213.69","article-title":"CD44 in cancer progression: adhesion, migration and growth regulation","volume":"35","author":"Marhaba","year":"2004","journal-title":"J Mol Histol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1023\/A:1019589923706","article-title":"CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors","volume":"33","author":"Stavropoulos","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0025","first-page":"75","article-title":"Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer","volume":"24","author":"Watanabe","year":"2005","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.016_bb0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.bjc.6605762","article-title":"Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer","volume":"103","author":"Lugli","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2013.02.016_bb0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2741\/3693","article-title":"Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer","volume":"16","author":"Curley","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.humpath.2013.02.016_bb0040","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/djj495","article-title":"The response of CD24(\u2212\/low)\/CD44+ breast cancer\u2013initiating cells to radiation","volume":"98","author":"Phillips","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2013.02.016_bb0045","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1097\/00029330-200810020-00006","article-title":"A novel mouse model of human breast cancer stem-like cells with high CD44+CD24\u2212\/lower phenotype metastasis to human bone","volume":"121","author":"Ling","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.humpath.2013.02.016_bb0050","first-page":"2147","article-title":"The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24\u2212\/low subpopulation and the side population of breast cancer cells","volume":"29","author":"Tanaka","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2013.02.016_bb0055","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00018-010-0420-9","article-title":"Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line","volume":"67","author":"Shi","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2013.02.016_bb0060","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ijc.24061","article-title":"Characterization of a subpopulation of colon cancer cells with stem cell-like properties","volume":"124","author":"Chu","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2013.02.016_bb0065","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","article-title":"Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells","volume":"25","author":"Patrawala","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2013.02.016_bb0070","first-page":"5318","article-title":"CD44 expression indicates favorable prognosis in epithelial ovarian cancer","volume":"9","author":"Sillanpaa","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.016_bb0075","first-page":"1665","article-title":"CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival","volume":"24","author":"Zagorianakou","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2013.02.016_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1440-1827.2006.01925.x","article-title":"Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms","volume":"56","author":"Cho","year":"2006","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2013.02.016_bb0085","series-title":"Pathology and Genetics of Tumours of the Breast and Female Genital Organs","first-page":"117","author":"Tavassoeli","year":"2003"},{"key":"10.1016\/j.humpath.2013.02.016_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/00313027909063533","article-title":"The pathological assessment of ovarian neoplasms. I: Introduction to the common \u2018epithelial' tumours and analysis of benign \u2018epithelial' tumours","volume":"11","author":"Russell","year":"1979","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2013.02.016_bb0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/00313027909061951","article-title":"The pathological assessment of ovarian neoplasms. II: The proliferating \u2018epithelial\u2019 tumours","volume":"11","author":"Russell","year":"1979","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2013.02.016_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/00313027909059027","article-title":"The pathological assessment of ovarian neoplasms. III: The malignant \u201cepithelial\u201d tumours","volume":"11","author":"Russell","year":"1979","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2013.02.016_bb0105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1471-0528.1989.tb03341.x","article-title":"Revised FIGO staging for gynaecological cancer","volume":"96","author":"Shepherd","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1200\/JCO.1997.15.1.172","article-title":"Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125","volume":"15","author":"Rustin","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/oxfordjournals.annonc.a010602","article-title":"Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study","volume":"7","author":"Rustin","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0125","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cncr.21767","article-title":"Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma","volume":"106","author":"Rosen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.02.016_bb0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/MO:20:3:255","article-title":"The CD44 receptor is a molecular predictor of survival in ovarian cancer","volume":"20","author":"Rodriguez-Rodriguez","year":"2003","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00022744-200112000-00004","article-title":"Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas","volume":"9","author":"Afify","year":"2001","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1006711320107","article-title":"Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma\u2014diagnostic and prognostic implications","volume":"18","author":"Berner","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.humpath.2013.02.016_bb0145","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1006756518500","article-title":"Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan","volume":"17","author":"Catterall","year":"1999","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.humpath.2013.02.016_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0165-4608(92)90225-W","article-title":"A multidrug-resistant ovarian carcinoma cell line with a malignant suppressed phenotype is a CD44 gene expression defective mutant","volume":"60","author":"Teyssier","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2013.02.016_bb0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1309\/KUK0-1M3D-LGNE-THXR","article-title":"Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas","volume":"116","author":"Ross","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2013.02.016_bb0160","doi-asserted-by":"crossref","first-page":"11961","DOI":"10.1074\/jbc.M411985200","article-title":"Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1\/estrogen receptor transcriptional activation, and ovarian cancer progression","volume":"280","author":"Bourguignon","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2013.02.016_bb0165","first-page":"1228","article-title":"In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation","volume":"57","author":"Strobel","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.016_bb0170","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0002-9440(10)65406-5","article-title":"CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells","volume":"154","author":"Lessan","year":"1999","journal-title":"Am J Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T13:12:09Z","timestamp":1563023529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0046817713001032"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.02.016","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}